Skip to content
Menu
Get the app WatchlistsPortfoliosAlerts
Pricing Sign in

Predictive Oncology Inc. POAI

Full chart Compare
Set alert

Price alert · POAI

All alert types
4.91 USD 0.00 (+0.00%)

As ofApr 21, 2026, 3:59 PM EDT

4.21 Day range 4.98

52-week range unavailable

YTD
+498.78%
1 year
+520.73%

Included in Essentials and up

Sign in to see Fair value

Discounted cash flow estimates against the price, and the P/E against its industry and sector.

Sign in

Included in Essentials and up

Sign in to see Head count and owner earnings

Employees by annual report and the cash the business earns for its owners.

Sign in

Financial health

Altman Z-Score

-14.18 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.4×
FY 2016: -18.2×FY 2017: -16.1×FY 2018: -11.8×FY 2019: -5.7×FY 2020: -5.0×FY 2021: -39.9×FY 2022: -13.2×FY 2023: -14.2×FY 2024: -5.5×FY 2025: -0.4×
FY 2016 5y median -13.2× FY 2025
P/S 828×
FY 2016: 260×FY 2017: 147×FY 2018: 84.3×FY 2019: 78.4×FY 2020: 103×FY 2021: 549×FY 2022: 225×FY 2023: 122×FY 2024: 41.3×FY 2025: 828×
FY 2016 5y median 225× FY 2025
P/B 2.2×
FY 2016: 128×FY 2017: 35.8×FY 2018: 2225×FY 2019: 9.9×FY 2020: 48.6×FY 2021: 19.4×FY 2022: 15.6×FY 2023: 24.0×FY 2024: -331×FY 2025: 2.2×
FY 2016 5y median 15.6× FY 2025
P/FCF -10.4×
FY 2016: -26.8×FY 2017: -21.4×FY 2018: -21.6×FY 2019: -12.6×FY 2020: -10.2×FY 2021: -59.2×FY 2022: -26.4×FY 2023: -15.0×FY 2024: -5.6×FY 2025: -10.4×
FY 2016 5y median -15.0× FY 2025
EV/EBITDA -0.4×
FY 2016: -18.1×FY 2017: -16.0×FY 2018: -15.6×FY 2019: -8.9×FY 2020: -11.7×FY 2021: -62.0×FY 2022: -22.8×FY 2023: -17.0×FY 2024: -6.7×FY 2025: -0.4×
FY 2016 5y median -17.0× FY 2025
EV/Sales 755×
FY 2016: 256×FY 2017: 146×FY 2018: 85.3×FY 2019: 82.5×FY 2020: 107×FY 2021: 530×FY 2022: 211×FY 2023: 118×FY 2024: 42.2×FY 2025: 755×
FY 2016 5y median 211× FY 2025
FCF Yield -9.6%
FY 2016: -3.7%FY 2017: -4.7%FY 2018: -4.6%FY 2019: -7.9%FY 2020: -9.8%FY 2021: -1.7%FY 2022: -3.8%FY 2023: -6.7%FY 2024: -17.8%FY 2025: -9.6%
FY 2016 5y median -6.7% FY 2025

Profitability

Gross Margin 42.0%
FY 2016: 60.2%FY 2017: 77.4%FY 2018: 70.5%FY 2019: 62.3%FY 2020: 64.3%FY 2021: 65.7%FY 2022: 66.4%FY 2023: 62.6%FY 2024: 49.1%FY 2025: 42.0%
FY 2016 5y median 62.6% FY 2025
Operating Margin -22688.6%
FY 2016: -1429.6%FY 2017: -1183.0%FY 2018: -556.9%FY 2019: -1604.2%FY 2020: -2025.1%FY 2021: -1437.9%FY 2022: -1729.3%FY 2023: -744.5%FY 2024: -673.7%FY 2025: -22688.6%
FY 2016 5y median -1437.9% FY 2025
Net Margin -186053.4%
FY 2016: -1429.6%FY 2017: -1183.0%FY 2018: -714.5%FY 2019: -1373.7%FY 2020: -2067.0%FY 2021: -1383.6%FY 2022: -1709.6%FY 2023: -859.1%FY 2024: -751.4%FY 2025: -186053.4%
FY 2016 5y median -1383.6% FY 2025
ROE -488.5%
FY 2016: -706.5%FY 2017: -287.8%FY 2018: -18863.1%FY 2019: -172.6%FY 2020: -979.5%FY 2021: -48.8%FY 2022: -118.2%FY 2023: -169.1%FY 2024: 6022.0%FY 2025: -488.5%
FY 2016 5y median -118.2% FY 2025
ROIC -57.6%
FY 2016: -529.1%FY 2017: -287.8%FY 2018: -465.6%FY 2019: -131.5%FY 2020: -289.7%FY 2021: -48.0%FY 2022: -118.6%FY 2023: -109.5%FY 2024: -560.5%FY 2025: -57.6%
FY 2016 5y median -109.5% FY 2025
ROA -440.7%
FY 2016: -232.4%FY 2017: -213.7%FY 2018: -271.9%FY 2019: -86.7%FY 2020: -198.2%FY 2021: -44.9%FY 2022: -100.0%FY 2023: -97.0%FY 2024: -245.4%FY 2025: -440.7%
FY 2016 5y median -100.0% FY 2025

Growth (YoY)

Revenue -92.3%
FY 2016: -30.2%FY 2017: 43.4%FY 2018: 115.6%FY 2019: -0.0%FY 2020: -11.3%FY 2021: 13.4%FY 2022: 6.0%FY 2023: 8.1%FY 2024: -0.2%FY 2025: -92.3%
FY 2016 FY 2025
Operating Income -159.8%
FY 2016: -48.3%FY 2017: -18.7%FY 2018: -1.5%FY 2019: -188.1%FY 2020: -12.0%FY 2021: 19.4%FY 2022: -27.4%FY 2023: 53.5%FY 2024: 9.7%FY 2025: -159.8%
FY 2016 FY 2025
EPS (diluted) -496.9%
FY 2016: -50.7%FY 2017: 59.2%FY 2018: 16.6%FY 2019: 12.8%FY 2020: 67.7%FY 2021: 83.7%FY 2022: 3.1%FY 2023: 50.1%FY 2024: 35.6%FY 2025: -496.9%
FY 2016 FY 2025
Free Cash Flow 16.8%
FY 2016: 41.4%FY 2017: -2.0%FY 2018: -22.3%FY 2019: -58.7%FY 2020: -44.1%FY 2021: -4.4%FY 2022: 2.5%FY 2023: -2.8%FY 2024: 9.4%FY 2025: 16.8%
FY 2016 FY 2025

Financial Health

Current Ratio 10.0×
FY 2016: 1.7×FY 2017: 2.5×FY 2018: 0.4×FY 2019: 0.1×FY 2020: 0.2×FY 2021: 9.1×FY 2022: 6.0×FY 2023: 2.6×FY 2024: 0.6×FY 2025: 10.0×
FY 2016 5y median 6.0× FY 2025
Quick Ratio 4.3×
FY 2016: 1.5×FY 2017: 2.3×FY 2018: 0.3×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 9.0×FY 2022: 5.9×FY 2023: 2.4×FY 2024: 0.5×FY 2025: 4.3×
FY 2016 5y median 4.3× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 30.6×FY 2019: 0.5×FY 2020: 2.2×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.3×FY 2024: -10.5×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.0×
FY 2016: 0.3×FY 2017: 0.1×FY 2018: -0.2×FY 2019: -0.4×FY 2020: -0.5×FY 2021: 2.3×FY 2022: 1.6×FY 2023: 0.5×FY 2024: -0.1×FY 2025: 0.0×
FY 2016 5y median 0.5× FY 2025
Interest Coverage 0.0×
FY 2016: -2175337×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -2.4×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31